Handbook of Incretin-based Therapies in Type 2 Diabetes

1. Auflage 2016
ISBN: 978-3-319-08981-2
Verlag: Springer International Publishing

Buch, Englisch, 92 Seiten, Format (B × H): 127 mm x 203 mm, Gewicht: 1209 g

This concise handbook provides an overview of incretin-based therapies and guidance for incorporating them into the treatment of type 2 diabetes. Chapters include landmark clinical trials and international treatment guidelines in order to update readers with all major advances in the field. An ideal resource for medical professionals that treat patients with type 2 diabetes in hospital and clinical settings.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Gough, Stephen

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Stoffwechselstörungen
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Diabetologie

Inhaltsverzeichnis

Introduction and disease overview.- Incretin hormones as a target for therapy.- Glucagon-like peptide receptor agonists.- Dipeptidyl peptidase-4 inhibitors.- Global position and recommendations for use.- Future and emerging therapies.

Über Autor(innen)

Stephen Gough is Professor of Diabetes at the University of Oxford and Consultant Physician at the Oxford University Hospitals NHS Trust. Professor Gough graduated in medicine from Leeds University Medical School, where he was later awarded a higher degree Doctorate in Medicine, which focused on cardiac dysfunction and abnormalities in coagulation and fibrinolysis present at the time of diagnosis of type 2 diabetes. He is currently based at the Oxford Centre for Diabetes, Endocrinology and Metabolism, where he is a practicing clinician in diabetes. His research interests and ongoing research studies include translational aspects of diabetes, with a focus on the physiology of islet cell and whole organ pancreas transplantation, incretin biology, and incretin therapies in diabetes. Professor Gough has previously had a strong interest in the genetic susceptibility to autoimmunity and this work has been extended into his work on pancreas transplantation. He has published his research extensively in peer-reviewed journals and has contributed to many national and international conferences and books on diabetes. In recent years, Professor Gough has helped develop translation research in diabetes in Oxford through a number of local and national initiatives, including the Oxford Biomedical Research Centre, and he is Clinical Lead in Diabetes for the Oxford Academic Health Science Network and the Oxford Local Clinical Research Network.

Addendum

Since editing this book, Professor Gough has taken up the position of Senior Principal Clinical Scientist with Novo Nordisk. He continues as Visiting Professor of Diabetes at the University of Oxford and Honorary Consultant with the Oxford University Hospitals NHS Trust.